1.

Short- and long-term antidepressant effects of ketamine in a rat chronic unpredictable stress model.

Jiang Y, Wang Y, Sun X, Lian B, Sun H, Wang G, Du Z, Li Q, Sun L.

Brain Behav. 2017 Jun 23;7(8):e00749. doi: 10.1002/brb3.749. eCollection 2017 Aug.

2.

Effects of systemic glutamatergic manipulations on conditioned eyeblink responses and hyperarousal in a rabbit model of post-traumatic stress disorder.

Burhans LB, Smith-Bell CA, Schreurs BG.

Behav Pharmacol. 2017 Oct;28(7):565-577. doi: 10.1097/FBP.0000000000000333.

PMID:
28799954
3.

Rapid infusion of esketamine for unipolar and bipolar depression: a retrospective chart review.

Correia-Melo FS, Argolo FC, Araújo-de-Freitas L, Leal GC, Kapczinski F, Lacerda AL, Quarantini LC.

Neuropsychiatr Dis Treat. 2017 Jun 21;13:1627-1632. doi: 10.2147/NDT.S135623. eCollection 2017.

4.

A Double-Blind, Placebo-Controlled, Pilot Study of Riluzole Monotherapy for Acute Bipolar Depression.

Park LT, Lener MS, Hopkins M, Iadorola N, Machado-Vieira R, Ballard E, Nugent A, Zarate CA Jr.

J Clin Psychopharmacol. 2017 Jun;37(3):355-358. doi: 10.1097/JCP.0000000000000693.

PMID:
28338546
5.

Glial GLT-1 blockade in infralimbic cortex as a new strategy to evoke rapid antidepressant-like effects in rats.

Gasull-Camós J, Tarrés-Gatius M, Artigas F, Castañé A.

Transl Psychiatry. 2017 Feb 21;7(2):e1038. doi: 10.1038/tp.2017.7.

6.

Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?

Jeon SW, Kim YK.

World J Psychiatry. 2016 Sep 22;6(3):283-93. doi: 10.5498/wjp.v6.i3.283. eCollection 2016 Sep 22. Review.

7.

Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.

Haroon E, Miller AH, Sanacora G.

Neuropsychopharmacology. 2017 Jan;42(1):193-215. doi: 10.1038/npp.2016.199. Epub 2016 Sep 15.

PMID:
27629368
8.

Pushing the threshold: How NMDAR antagonists induce homeostasis through protein synthesis to remedy depression.

Raab-Graham KF, Workman ER, Namjoshi S, Niere F.

Brain Res. 2016 Sep 15;1647:94-104. doi: 10.1016/j.brainres.2016.04.020. Epub 2016 Apr 26. Review.

PMID:
27125595
9.

Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.

Hashimoto K, Bruno D, Nierenberg J, Marmar CR, Zetterberg H, Blennow K, Pomara N.

Transl Psychiatry. 2016 Mar 1;6:e744. doi: 10.1038/tp.2016.8.

10.

The role of leptin in central nervous system diseases.

Li XM, Yan HJ, Guo YS, Wang D.

Neuroreport. 2016 Mar 23;27(5):350-5. doi: 10.1097/WNR.0000000000000546. Review.

11.

Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Cobb JA, O'Neill K, Milner J, Mahajan GJ, Lawrence TJ, May WL, Miguel-Hidalgo J, Rajkowska G, Stockmeier CA.

Neuroscience. 2016 Mar 1;316:209-20. doi: 10.1016/j.neuroscience.2015.12.044. Epub 2015 Dec 30.

12.

New targets for rapid antidepressant action.

Machado-Vieira R, Henter ID, Zarate CA Jr.

Prog Neurobiol. 2017 May;152:21-37. doi: 10.1016/j.pneurobio.2015.12.001. Epub 2015 Dec 23. Review.

PMID:
26724279
13.

Emergent treatments based on the pathophysiology of bipolar disorder: A selective review.

Brady RO, Keshavan M.

Asian J Psychiatr. 2015 Dec;18:15-21. doi: 10.1016/j.ajp.2015.07.017. Epub 2015 Sep 28. Review.

14.

Translational Research in Bipolar Disorders.

Machado-Vieira R, Frey BN, Andreazza AC, Quevedo J.

Neural Plast. 2015;2015:576978. doi: 10.1155/2015/576978. Epub 2015 Jun 14. No abstract available.

15.

Long-term NMDAR antagonism correlates reduced astrocytic glutamate uptake with anxiety-like phenotype.

Zimmer ER, Torrez VR, Kalinine E, Augustin MC, Zenki KC, Almeida RF, Hansel G, Muller AP, Souza DO, Machado-Vieira R, Portela LV.

Front Cell Neurosci. 2015 Jun 3;9:219. doi: 10.3389/fncel.2015.00219. eCollection 2015. Erratum in: Front Cell Neurosci. 2016;10:93.

16.

Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation.

Lally N, An L, Banerjee D, Niciu MJ, Luckenbaugh DA, Richards EM, Roiser JP, Shen J, Zarate CA Jr, Nugent AC.

J Magn Reson Imaging. 2016 Jan;43(1):88-98. doi: 10.1002/jmri.24970. Epub 2015 Jun 7.

17.

Riluzole stimulates BDNF release from human platelets.

Türck P, Frizzo ME.

Biomed Res Int. 2015;2015:189307. doi: 10.1155/2015/189307. Epub 2015 Jan 6.

18.

Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.

Zhang JC, Wu J, Fujita Y, Yao W, Ren Q, Yang C, Li SX, Shirayama Y, Hashimoto K.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4). pii: pyu077. doi: 10.1093/ijnp/pyu077.

19.

Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.

Bunney BG, Li JZ, Walsh DM, Stein R, Vawter MP, Cartagena P, Barchas JD, Schatzberg AF, Myers RM, Watson SJ, Akil H, Bunney WE.

Mol Psychiatry. 2015 Feb;20(1):48-55. doi: 10.1038/mp.2014.138. Epub 2014 Nov 4. Review.

20.

Toward a biosignature for suicide.

Oquendo MA, Sullivan GM, Sudol K, Baca-Garcia E, Stanley BH, Sublette ME, Mann JJ.

Am J Psychiatry. 2014 Dec 1;171(12):1259-77. doi: 10.1176/appi.ajp.2014.14020194. Epub 2014 Oct 31. Review.

Supplemental Content

Loading ...
Support Center